Journal article
Prognostic Association between Common Laboratory Tests and Overall Survival in Elderly Men with De Novo Metastatic Castration Sensitive Prostate Cancer: A Population-Based Study in Canada
Abstract
De novo cases of metastatic prostate cancer (mCSPC) are associated with poorer prognosis. To assist in clinical decision-making, we aimed to determine the prognostic utility of commonly available laboratory-based markers with overall survival (OS). In a retrospective population-based study, a cohort of 3556 men aged ≥66 years diagnosed with de novo mCSPC between 2014 and 2019 was identified in Ontario (Canada) administrative database. OS was …
Authors
Wallis CJD; Shayegan B; Morgan SC; Hamilton RJ; Cagiannos I; Basappa NS; Ferrario C; Gotto GT; Fernandes R; Roy S
Journal
Cancers, Vol. 13, No. 11,
Publisher
MDPI
DOI
10.3390/cancers13112844
ISSN
2072-6694